Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: epidemiology and resistance features. Saudi J Biol Sci. 2018;25(3):586–96.

Article  PubMed  Google Scholar 

Sohail M, Rashid A, Aslam B, Waseem M, Shahid M, Akram M, et al. Antimicrobial susceptibility of Acinetobacter clinical isolates and emerging antibiogram trends for nosocomial infection management. Rev Soc Bras Med Trop. 2016;49(3):300–4.

Article  PubMed  Google Scholar 

Vázquez-López R, Solano-Gálvez SG, Juárez Vignon-Whaley JJ, Abello Vaamonde JA, Padró Alonzo LA, Rivera Reséndiz A, et al. Acinetobacter baumannii resistance: a real challenge for clinicians. Antibiotics (Basel). 2020;9(4):205.

Article  PubMed  Google Scholar 

Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist. 2018;11:1249–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng DY, Zhou JX, Li X, Wu WB, Zhou YQ, Zhang TT. Differentiation between Acinetobacter baumannii colonization and infection and the clinical outcome prediction by infection in lower respiratory tract. Infect Drug Resist. 2022;15:5401–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jung J, Park W. Acinetobacter species as model microorganisms in environmental microbiology: current state and perspectives. Appl Microbiol Biotechnol. 2015;99(6):2533–48.

Article  CAS  PubMed  Google Scholar 

World Health Organization (WHO). Care, cleaning and disinfection of respiratory equipment in sterile services department. 2021. https://www.who.int/publications/m/item/care-cleaning-and-disinfection-of-respiratory-equipment-in-sterile-services-department

Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. 2021;48(10):6987–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goic-Barisic I, Seruga Music M, Kovacic A, Tonkic M, Hrenovic J. Pan drug-resistant environmental isolate of Acinetobacter baumannii from Croatia. Microb Drug Resist. 2017;23(4):494–6.

Article  CAS  PubMed  Google Scholar 

Weinberg SE, Villedieu A, Bagdasarian N, Karah N, Teare L, Elamin WF. Control and management of multidrug resistant Acinetobacter baumannii: a review of the evidence and proposal of novel approaches. Infection Prevention in Practice. 2020;2(3):100077.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayoub Moubareck C, Hammoudi HD. Insights into Acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics. 2020;9(3):119.

Article  PubMed  PubMed Central  Google Scholar 

Gandra S, Mojica N, Klein EY, Ashok A, Nerurkar V, Kumari M, et al. Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008–2014. Int J Infect Dis. 2016;50:75–82.

Article  PubMed  PubMed Central  Google Scholar 

Asokan G, Ramadhan T, Ahmed E, Sanad H. WHO global priority pathogens list: a bibliometric analysis of medline-pubmed for knowledge mobilization to infection prevention and control practices in Bahrain. Oman Med J. 2019;34(3):184–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, et al. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020;33(3):10–1128.

Article  Google Scholar 

Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013;11(3):297–308.

Article  CAS  PubMed  Google Scholar 

Uwingabiye J, Frikh M, Lemnouer A, Bssaibis F, Belefquih B, Maleb A, et al. Acinetobacter infections prevalence and frequency of the antibiotics resistance: comparative study of intensive care units versus other hospital units. Pan Afr Med J. 2016;23.

Mat Rahim N, Lee H, Strych U, AbuBakar S. Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development. Hum Vaccin Immunother. 2021;17(10):3784–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma C, McClean S. Mapping global prevalence of Acinetobacter baumannii and recent vaccine development to tackle it. Vaccines (Basel). 2021;9(6):570.

Article  PubMed  Google Scholar 

Chamoun K, Farah M, Araj G, Daoud Z, Moghnieh R, Salameh P, et al. Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. Int J Infect Dis. 2016;46:64–70.

Article  CAS  PubMed  Google Scholar 

Rima M, Oueslati S, Dabos L, Daaboul D, Mallat H, Bou Raad E, et al. Prevalence and molecular mechanisms of carbapenem resistance among gram-negative bacilli in three hospitals of Northern Lebanon. Antibiotics. 2022;11(10):1295.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rafei R, Pailhoriès H, Hamze M, Eveillard M, Mallat H, Dabboussi F, et al. Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using blaOXA-51-like sequence based typing. BMC Microbiol. 2015;15:103.

Article  PubMed  PubMed Central  Google Scholar 

Clinical and Laboratory Standards Institute. M100 Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI; 2020.

Strauss M, Zoabi K, Sagas D, Reznik-Gitlitz B, Colodner R. Evaluation of Bio-Rad® discs for antimicrobial susceptibility testing by disc diffusion and the ADAGIO™ system for the automatic reading and interpretation of results. Eur J Clin Microbiol Infect Dis. 2020;39(2):375–84.

Article  CAS  PubMed  Google Scholar 

Kucukler E. Risk factors of Acinetobacter baumannii infections. Int J Infect Dis. 2014;21:420.

Article  Google Scholar 

García-Garmendia J, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jiménez F, Pérez-Paredes C, Barrero-Almodóvar AE, et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis. 2001;33(7):939–46.

Article  PubMed  Google Scholar 

Zhou H, Yao Y, Zhu B, Ren D, Yang Q, Fu Y, et al. Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia. Medicine. 2019;98(13):e14937.

Article  PubMed  PubMed Central  Google Scholar 

Yang YS, Lee YT, Huang TW, Sun JR, Kuo SC, Yang CH, et al. Acinetobacter baumannii nosocomial pneumonia: Is the outcome more favorable in non-ventilated than ventilated patients? BMC Infect Dis. 2013;13(1):142.

Article  PubMed  PubMed Central  Google Scholar 

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.

Article  CAS  PubMed  Google Scholar 

McKay SL, Vlachos N, Daniels JB, Albrecht VS, Stevens VA, Rasheed JK, et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in the United States, 2013–2017. Microb Drug Resist. 2022;28(6):645–53.

Article  CAS  PubMed  Google Scholar 

Balkhair A, Al-Muharrmi Z, Al’Adawi B, Al Busaidi I, Taher HB, Al-Siyabi T, et al. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: description of a decade-long trend. Int J Infect Dis. 2019;85:10–5.

Article  CAS  PubMed  Google Scholar 

World Medical Association Declaration of Helsinki. JAMA. 2013;310(20):2191.

Monegro AF, Muppidi V, Regunath H. StatPearls Publishing. 2023. Hospital-Acquired Infections. https://www.ncbi.nlm.nih.gov/books/NBK441857/

Alotaibi T, Abuhaimed A, Alshahrani M, Albdelhady A, Almubarak Y, Almasari O. Prevalence of multidrug-resistant Acinetobacter baumannii in a critical care setting: a tertiary teaching hospital experience. SAGE Open Med. 2021;9:1–5.

Article  Google Scholar 

Kanafani ZA, Zahreddine N, Tayyar R, Sfeir J, Araj GF, Matar GM, et al. Multi-drug resistant Acinetobacter species: a seven-year experience from a tertiary care center in Lebanon. Antimicrob Resist Infect Control. 2018;7:9.

Article  PubMed  PubMed Central  Google Scholar 

Nowak J, Zander E, Stefanik D, Higgins PG, Roca I, Vila J, et al. High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J Antimicrob Chemother. 2017;72(12):3277–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al Atrouni A, Hamze M, Jisr T, Lemarié C, Eveillard M, Joly-Guillou ML, et al. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon. Int J Infect Dis. 2016;52:29–36.

Article  CAS  PubMed  Google Scholar 

Hammoudi Halat D, Moubareck CA, Sarkis DK. Heterogeneity of carbapenem resistance mechanisms among gram-negative pathogens in Lebanon: results of the first cross-sectional countrywide study. Microb Drug Resist. 2017;23(6):733–43.

Article  CAS  PubMed  Google Scholar 

Nawfal Dagher T, Al-Bayssari C, Chabou S, Antar N, Diene SM, Azar E, et al. Investigation of multidrug-resistant ST2 Acinetobacter baumannii isolated from Saint George hospital in Lebanon. BMC Microbiol. 2019;19(1):29.

Article  PubMed  PubMed Central  Google Scholar 

Makke G, Bitar I, Salloum T, Panossian B, Alousi S, Arabaghian H, et al. Whole-genome-sequence-based characterization of extensively drug-resistant Acinetobacter baumannii Hospital outbreak. mSphere. 2020;5(1):e00934-19.